IL17A and Huntington disease: Increased levels of Interleukin-17 (IL-17), a pro-inflammatory cytokine secreted by activated T-cells as well as an increased prevalence of IL-17–producing Th17.1 cells in the CSF of premanifest HD mutation carriers further underlines inflammation as an early and important part the pathophysiology in HD [24].